CY1110359T1 - Εμβολια με βαση σιρκοϊους χοιρων - Google Patents
Εμβολια με βαση σιρκοϊους χοιρωνInfo
- Publication number
- CY1110359T1 CY1110359T1 CY20051101221T CY051101221T CY1110359T1 CY 1110359 T1 CY1110359 T1 CY 1110359T1 CY 20051101221 T CY20051101221 T CY 20051101221T CY 051101221 T CY051101221 T CY 051101221T CY 1110359 T1 CY1110359 T1 CY 1110359T1
- Authority
- CY
- Cyprus
- Prior art keywords
- vaccines
- expression vector
- relates
- plasmid
- swine
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000282898 Sus scrofa Species 0.000 title 1
- 239000013604 expression vector Substances 0.000 abstract 2
- 239000013612 plasmid Substances 0.000 abstract 2
- 208000003098 Ganglion Cysts Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 208000005400 Synovial Cyst Diseases 0.000 abstract 1
- 108010008038 Synthetic Vaccines Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 229940031567 attenuated vaccine Drugs 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 229940031551 inactivated vaccine Drugs 0.000 abstract 1
- 238000010348 incorporation Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000002685 pulmonary effect Effects 0.000 abstract 1
- 229940124551 recombinant vaccine Drugs 0.000 abstract 1
- 229940031626 subunit vaccine Drugs 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/02—Making cheese curd
- A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
- A23C19/0321—Propionic acid bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/02—Making cheese curd
- A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
- A23C19/0323—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10041—Use of virus, viral particle or viral elements as a vector
- C12N2750/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10061—Methods of inactivation or attenuation
- C12N2750/10064—Methods of inactivation or attenuation by serial passage
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Η παρούσα εφεύρεση έχει σχέση με στελέχη σιρκοϊού χοίρου που απομονώνονται από πνευμονικά και γαγγλιακά δείγματα που προέρχονται από ζώα εκτροφής που έχουν προσβληθεί από το σύνδρομο του γενικευμένου μαρασμού μετά τον απογαλακτισμό (στα αγγλικά PMWS). Αναφέρεται επίσης σε καθαρισμένα παρασκευάσματα των στελεχών αυτών, σε κλασικά εμβόλια εξασθενημένα ή αδρανοποιημένα, σε ζωντανά ανασυνδυαστικά εμβόλια, σε πλασμιδικά εμβόλια και σε εμβόλια υπο-μονάδων, όπως επίσης σε αντιδραστήρια και μεθόδους διάγνωσης. Έχει σχέση επίσης με DNA κομμάτια που μπορούν να χρησιμοποιηθούν για την παραγωγή υπο-μονάδων σε ένα ενδιάμεσο ξενιστή έκφρασης in vitro ή ως αλληλουχίες προς ενσωμάτωση μέσα σε ένα ενδιάμεσο ξενιστή έκφρασης in vivo τύπου ιού ή πλασμιδίου.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9712382A FR2769321B1 (fr) | 1997-10-03 | 1997-10-03 | Nouveaux circovirus porcins, vaccins et reactifs de diagnostics |
FR9800873A FR2769322B1 (fr) | 1997-10-03 | 1998-01-22 | Nouveaux circovirus porcins, vaccins et reactifs de diagnostic |
FR9803707A FR2776294B1 (fr) | 1998-03-20 | 1998-03-20 | Nouveaux circovirus porcins ; vaccins et reactifs de diagnostic |
EP02017134A EP1281760B9 (fr) | 1997-10-03 | 1998-10-01 | Circovirus porcins |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1110359T1 true CY1110359T1 (el) | 2015-04-29 |
Family
ID=27253376
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20051101221T CY1110359T1 (el) | 1997-10-03 | 2005-10-07 | Εμβολια με βαση σιρκοϊους χοιρων |
CY20081100583T CY1108113T1 (el) | 1997-10-03 | 2008-06-03 | Μεθοδος διαγνωσεως ιν vitro της μολυνσεως απο σιρκoïο χοιρων τυπου ιι και αντιδραστηρια διαγνωσεως |
CY20141100947T CY1115749T1 (el) | 1997-10-03 | 2014-11-13 | Κυκλοϊος χοιρων, νουκλεϊνικα οξεα, πολυπεπτιδια και εμβολια |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081100583T CY1108113T1 (el) | 1997-10-03 | 2008-06-03 | Μεθοδος διαγνωσεως ιν vitro της μολυνσεως απο σιρκoïο χοιρων τυπου ιι και αντιδραστηρια διαγνωσεως |
CY20141100947T CY1115749T1 (el) | 1997-10-03 | 2014-11-13 | Κυκλοϊος χοιρων, νουκλεϊνικα οξεα, πολυπεπτιδια και εμβολια |
Country Status (21)
Country | Link |
---|---|
US (1) | US6368601B1 (el) |
EP (4) | EP1019510B1 (el) |
JP (5) | JP5008218B2 (el) |
KR (4) | KR100736129B1 (el) |
CN (2) | CN101724606B (el) |
AT (3) | ATE245191T1 (el) |
AU (1) | AU756554C (el) |
BR (1) | BR9812845B1 (el) |
CA (1) | CA2305623C (el) |
CY (3) | CY1110359T1 (el) |
DE (7) | DE05014998T1 (el) |
DK (4) | DK1741785T3 (el) |
ES (4) | ES2203984T3 (el) |
FR (1) | FR05C0021I2 (el) |
HK (1) | HK1095161A1 (el) |
HU (2) | HU230340B1 (el) |
NL (1) | NL300326I2 (el) |
PL (1) | PL198506B1 (el) |
PT (4) | PT1386617E (el) |
UA (1) | UA78180C2 (el) |
WO (1) | WO1999018214A1 (el) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2781159B1 (fr) * | 1998-07-06 | 2000-10-06 | Merial Sas | Vaccin circovirus et parvovirus porcin |
US20060029617A1 (en) * | 1997-10-03 | 2006-02-09 | Charreyre Catherine E | Porcine circovirus and Helicobacter combination vaccines and methods of use |
US7192594B2 (en) * | 1997-10-03 | 2007-03-20 | Merial Limited | Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
US6517843B1 (en) * | 1999-08-31 | 2003-02-11 | Merial | Reduction of porcine circovirus-2 viral load with inactivated PCV-2 |
US6391314B1 (en) * | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
US7211379B2 (en) * | 1997-10-03 | 2007-05-01 | Merial Sas | Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
FR2772047B1 (fr) * | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
US20040062775A1 (en) * | 1997-12-05 | 2004-04-01 | Agence Francaise De Securite Sanitaire Des Aliments | Circovirus sequences associated with piglet weight loss disease (PWD) |
EP1816200B1 (en) * | 1997-12-11 | 2016-03-09 | Merial | Postweaning multisystemic wasting syndrome virus for pigs |
PT2363488E (pt) * | 1997-12-11 | 2015-01-13 | Univ Belfast | Síndrome multi-sistémica do definhamento pós-desmame de porcos |
US6943152B1 (en) | 1999-06-10 | 2005-09-13 | Merial | DNA vaccine-PCV |
US6497883B1 (en) * | 1999-06-10 | 2002-12-24 | Merial | Porcine circovirus recombinant poxvirus vaccine |
ES2170622B1 (es) * | 1999-12-03 | 2004-05-16 | Consejo Superior De Investigaciones Cientificas | Clones y vectores infectivos derivados de coronavirus y sus aplicaciones. |
WO2001096377A2 (en) * | 2000-06-15 | 2001-12-20 | Purdue Research Foundation | Vaccine for congenital tremors in pigs |
US7018638B2 (en) * | 2000-12-19 | 2006-03-28 | Wyeth | Mycoplasma hyopneumoniae bacterin vaccine |
MY148759A (en) * | 2001-03-27 | 2013-05-31 | Univ Saskatchewan | Methods to culture circovirus |
CA2454397A1 (en) | 2001-07-20 | 2003-06-05 | The University Of Georgia Research Foundation, Inc. | Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the cns |
US7276353B2 (en) | 2001-12-12 | 2007-10-02 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US7279166B2 (en) * | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
OA12915A (en) * | 2002-08-26 | 2006-10-13 | Pfizer Prod Inc | Vaccine for respiratory and reproductive system infections in cattle. |
KR20040021988A (ko) * | 2002-09-06 | 2004-03-11 | 서상희 | 바이러스 증식용 돼지 신장 상피 세포주, 및 이의 용도 |
UA95602C2 (ru) | 2004-12-30 | 2011-08-25 | Берингер Ингельхейм Ветмедика, Инк. | Иммуногенная композиция цвс2 и способы приготовления такой композиции |
US7700285B1 (en) | 2005-12-29 | 2010-04-20 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 immunogenic compositions and methods of producing such compositions |
US7833707B2 (en) | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
US8834891B2 (en) * | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
EP1869471B1 (en) * | 2005-04-13 | 2016-06-08 | Merial, Inc. | Method for porcine circovirus production |
EP1792996A1 (en) * | 2005-12-01 | 2007-06-06 | Consejo Superior de Investigaciones Cientificas | Nucleic acid sequences encoding vaccines against Porcine reproductive and respiratory syndrome virus (PRRSV) |
PL1968630T3 (pl) | 2005-12-29 | 2018-08-31 | Boehringer Ingelheim Vetmedica, Inc. | Multiwalentne immunogenne kompozycje PCV2 |
CN104383526B (zh) * | 2005-12-29 | 2018-09-18 | 贝林格尔.英格海姆维特梅迪卡有限公司 | Pcv2免疫原性组合物用于减轻猪临床症状的用途 |
KR100870077B1 (ko) * | 2006-10-27 | 2008-11-25 | 권영득 | 이유후 전신소모성증후군(pmws)의 치료용 복합제조성물 |
US20100129397A1 (en) * | 2006-12-11 | 2010-05-27 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
EP2094872B2 (en) | 2006-12-15 | 2020-02-19 | Boehringer Ingelheim Animal Health USA Inc. | Treatment of anti-PCV2 antibody seropositive pigs with PCV2 antigen |
EP1941903A1 (en) | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxis and treatment of PRDC |
EP1958644A1 (en) | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Prevention and treatment of sub-clinical pcvd |
CA2687146C (en) * | 2007-05-11 | 2015-07-21 | Temasek Life Sciences Laboratory Limited | Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (pcv2) infection |
KR100948127B1 (ko) * | 2007-06-27 | 2010-03-18 | 주식회사 중앙백신연구소 | 복합호흡기 질환 돼지의 조직유제를 함유하는 백신 조성물 |
US20090017064A1 (en) * | 2007-07-10 | 2009-01-15 | Wyeth | Methods and Compositions for Immunizing Pigs Against Porcine Circovirus |
US7829274B2 (en) | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
EP2225367A1 (en) * | 2007-12-21 | 2010-09-08 | Wyeth LLC | Methods and compositions for immunizing pigs against porcine circovirus |
US20110020394A1 (en) * | 2007-12-31 | 2011-01-27 | Boehringer Ingelheim Vetmedica, Inc. | Pcv2 orf2 virus like particle with foreign amino acid insertion |
EP2242511A4 (en) * | 2008-01-23 | 2012-10-24 | Boehringer Ingelheim Vetmed | IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS |
AR078253A1 (es) * | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
TWI442935B (zh) | 2010-12-22 | 2014-07-01 | Sbc Virbac Ltd | 豬第二型環狀病毒(Porcine Circovirus Type 2)、含彼之免疫組合物、檢測套組及其應用 |
EP2564869A1 (en) | 2011-09-02 | 2013-03-06 | Ceva Sante Animale | Synthetic capsid proteins and uses thereof |
EP2789346A1 (en) | 2013-04-11 | 2014-10-15 | CEVA Santé Animale SA | Fusion polypeptides and vaccines |
US9649370B2 (en) | 2013-05-08 | 2017-05-16 | Protatek International, Inc. | Vaccine for PCV2 and mycoplasma |
JP6821429B2 (ja) | 2013-09-25 | 2021-01-27 | ゾエティス・サービシーズ・エルエルシー | Pcv2b分岐ワクチン組成物及び使用方法 |
EA035265B1 (ru) | 2013-10-02 | 2020-05-21 | Бёрингер Ингельхайм Энимал Хелс Ю-Эс-Эй Инк. | Вариант белка opc2 pcv2 и содержащие его вирусоподобные частицы |
CN104383527A (zh) * | 2014-11-18 | 2015-03-04 | 天津瑞普生物技术股份有限公司 | 一种猪圆环病毒2型灭活冻干疫苗的制备方法 |
EP3034609A1 (en) | 2014-12-19 | 2016-06-22 | Ceva Sante Animale | Recombinant swinepox virus and vaccines |
US9944904B2 (en) | 2015-05-14 | 2018-04-17 | Merial Inc. | Method for porcine circovirus production and PCV2 vaccines |
EP3254692A1 (en) | 2016-06-10 | 2017-12-13 | Ceva Sante Animale | Multivalent recombinant spv |
EP3720485A1 (en) | 2017-12-08 | 2020-10-14 | Ceva Sante Animale | Recombinant swinepox virus and vaccines |
JP7162072B2 (ja) | 2018-03-26 | 2022-10-27 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | 免疫原性組成物を製造する方法 |
WO2019238611A1 (en) | 2018-06-11 | 2019-12-19 | Ceva Sante Animale | Vaccination against porcine circoviruses |
KR102124260B1 (ko) * | 2018-10-19 | 2020-06-26 | 대한민국(관리부서 질병관리본부장) | 신속 면역크로마토그래피법을 이용한 콜레라균 진단·탐지 키트 및 이를 위한 특이항체와 항체생산세포주 |
BR112023001324A2 (pt) | 2020-07-24 | 2023-02-14 | Boehringer Ingelheim Animal Health Usa Inc | Combinação de vacina de suíno |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4745051A (en) | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
US4740468A (en) | 1985-02-14 | 1988-04-26 | Syntex (U.S.A.) Inc. | Concentrating immunochemical test device and method |
US5232835A (en) | 1986-11-07 | 1993-08-03 | Syntex (U.S.A.) Inc. | Qualitative immunochromatographic method and device |
US5030558A (en) | 1986-11-07 | 1991-07-09 | Syntex (U.S.A.) Inc. | Qualitative immunochromatographic method and device |
CA1303983C (en) | 1987-03-27 | 1992-06-23 | Robert W. Rosenstein | Solid phase assay |
EP1248112A3 (en) | 1987-04-27 | 2004-08-25 | Inverness Medical Switzerland GmbH | Immunochromatographic specific binding assay device |
US4855240A (en) | 1987-05-13 | 1989-08-08 | Becton Dickinson And Company | Solid phase assay employing capillary flow |
US5120643A (en) | 1987-07-13 | 1992-06-09 | Abbott Laboratories | Process for immunochromatography with colloidal particles |
DK175379B1 (da) * | 1987-09-28 | 2004-09-20 | Pfizer | Anvendelse af transmitterbart svine-gastro-enteritisvirus samt fremgangsmåde til fremstilling af en vaccine |
EP1026253B2 (en) | 1989-03-21 | 2012-12-19 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate |
FR2649013B1 (fr) | 1989-07-03 | 1991-10-25 | Seppic Sa | Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable |
US5141850A (en) | 1990-02-07 | 1992-08-25 | Hygeia Sciences, Inc. | Porous strip form assay device method |
JP3187419B2 (ja) | 1990-05-29 | 2001-07-11 | アメリカン・サイアナミド・カンパニー | ブタ肺炎ワクチンおよびその製造方法 |
US5238652A (en) | 1990-06-20 | 1993-08-24 | Drug Screening Systems, Inc. | Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques |
US5565205A (en) | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
US5266497A (en) | 1990-08-31 | 1993-11-30 | Japan Synthetic Rubber Co., Ltd. | Immunochromatographic assay with improved colored latex |
US5451504A (en) | 1991-07-29 | 1995-09-19 | Serex, Inc. | Method and device for detecting the presence of analyte in a sample |
WO1993007898A1 (en) | 1991-10-14 | 1993-04-29 | Akzo Nobel N.V. | Porcine reproductive respiratory syndrome vaccine and diagnostic |
US5338543A (en) * | 1992-02-27 | 1994-08-16 | Ambico, Inc. | Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
DE9204303U1 (de) | 1992-03-30 | 1992-06-25 | Marx, Günter Wolfgang, 7953 Bad Schussenried | Trainingsgerät |
EP0571648A1 (en) | 1992-05-26 | 1993-12-01 | Chung-Nan Weng | Vaccine protecting against mycoplasmal pneumonia |
US6592873B1 (en) * | 1992-10-30 | 2003-07-15 | Iowa State University Research Foundation, Inc. | Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
FR2700957B1 (fr) | 1993-01-29 | 1995-03-03 | Seppic Sa | Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation. |
ATE197314T1 (de) | 1993-02-08 | 2000-11-15 | Bayer Ag | Verfahren zum vermehren des das reproduktions- und atemwegs-syndrom verursachenden schweinevirus und dessen verwendung als impfstoff. |
FR2702373B1 (fr) | 1993-03-08 | 1996-06-07 | Rhone Merieux | Emulsions vaccinales fluides eau-dans-l'huile contenant une huile métabolisable. |
IL108915A0 (en) | 1993-03-18 | 1994-06-24 | Merck & Co Inc | Polynucleotide vaccine against influenza virus |
ES2074950B1 (es) | 1993-09-17 | 1996-03-16 | Iberica Cyanamid | Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda. |
DE69536091D1 (de) | 1994-01-27 | 2010-09-09 | Univ Massachusetts Medical | Immunisierung durch Impfung von DNS Transkriptionseinheit |
DE69522984T2 (de) * | 1994-04-11 | 2002-04-25 | Akzo Nobel Nv | Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Schweins |
CA2196865C (en) * | 1994-08-05 | 2001-07-03 | Karl P. Schneider | Self-chamfering drill bit |
FR2781159B1 (fr) * | 1998-07-06 | 2000-10-06 | Merial Sas | Vaccin circovirus et parvovirus porcin |
FR2772047B1 (fr) * | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
PT2363488E (pt) * | 1997-12-11 | 2015-01-13 | Univ Belfast | Síndrome multi-sistémica do definhamento pós-desmame de porcos |
KR100298125B1 (ko) * | 1999-04-15 | 2001-09-13 | 정명식 | 구리의 화학 증착에 유용한 유기 구리 전구체 |
-
1998
- 1998-01-10 UA UA2000042372A patent/UA78180C2/uk unknown
- 1998-05-21 US US09/082,558 patent/US6368601B1/en not_active Expired - Lifetime
- 1998-10-01 PT PT03016998T patent/PT1386617E/pt unknown
- 1998-10-01 DE DE05014998T patent/DE05014998T1/de active Pending
- 1998-10-01 KR KR1020007003628A patent/KR100736129B1/ko not_active IP Right Cessation
- 1998-10-01 EP EP98946547A patent/EP1019510B1/fr not_active Expired - Lifetime
- 1998-10-01 ES ES98946547T patent/ES2203984T3/es not_active Expired - Lifetime
- 1998-10-01 AU AU93555/98A patent/AU756554C/en not_active Expired
- 1998-10-01 DK DK05014998.8T patent/DK1741785T3/da active
- 1998-10-01 EP EP02017134A patent/EP1281760B9/fr not_active Expired - Lifetime
- 1998-10-01 DE DE122008000069C patent/DE122008000069I1/de active Pending
- 1998-10-01 DK DK98946547T patent/DK1019510T3/da active
- 1998-10-01 DE DE69816460T patent/DE69816460T2/de not_active Expired - Lifetime
- 1998-10-01 DK DK03016998T patent/DK1386617T3/da active
- 1998-10-01 HU HU0800330A patent/HU230340B1/hu unknown
- 1998-10-01 PT PT98946547T patent/PT1019510E/pt unknown
- 1998-10-01 AT AT98946547T patent/ATE245191T1/de active
- 1998-10-01 PT PT02017134T patent/PT1281760E/pt unknown
- 1998-10-01 AT AT03016998T patent/ATE387914T1/de active
- 1998-10-01 HU HU0003756A patent/HU226247B1/hu active Protection Beyond IP Right Term
- 1998-10-01 ES ES03016998T patent/ES2302885T3/es not_active Expired - Lifetime
- 1998-10-01 CN CN200910252636.4A patent/CN101724606B/zh not_active Expired - Lifetime
- 1998-10-01 PL PL339631A patent/PL198506B1/pl unknown
- 1998-10-01 KR KR1020087004310A patent/KR100904852B1/ko not_active IP Right Cessation
- 1998-10-01 WO PCT/FR1998/002107 patent/WO1999018214A1/fr not_active Application Discontinuation
- 1998-10-01 CA CA002305623A patent/CA2305623C/en not_active Expired - Lifetime
- 1998-10-01 EP EP03016998A patent/EP1386617B1/fr not_active Expired - Lifetime
- 1998-10-01 DK DK02017134T patent/DK1281760T5/da active
- 1998-10-01 DE DE69830858A patent/DE69830858D1/de not_active Expired - Lifetime
- 1998-10-01 DE DE200512000009 patent/DE122005000009I1/de active Pending
- 1998-10-01 KR KR1020067010174A patent/KR100854615B1/ko not_active IP Right Cessation
- 1998-10-01 EP EP05014998.8A patent/EP1741785B1/fr not_active Expired - Lifetime
- 1998-10-01 CN CN98810652A patent/CN100584948C/zh not_active Expired - Lifetime
- 1998-10-01 KR KR1020097009112A patent/KR100944144B1/ko not_active IP Right Cessation
- 1998-10-01 JP JP2000515010A patent/JP5008218B2/ja not_active Expired - Lifetime
- 1998-10-01 PT PT50149988T patent/PT1741785E/pt unknown
- 1998-10-01 BR BRPI9812845-0A patent/BR9812845B1/pt not_active IP Right Cessation
- 1998-10-01 AT AT02017134T patent/ATE299531T1/de active
- 1998-10-01 ES ES05014998.8T patent/ES2524359T3/es not_active Expired - Lifetime
- 1998-10-01 ES ES02017134T patent/ES2246001T3/es not_active Expired - Lifetime
- 1998-10-01 DE DE69830858T patent/DE69830858T4/de not_active Expired - Lifetime
- 1998-10-01 DE DE69839227T patent/DE69839227T2/de not_active Expired - Lifetime
-
2005
- 2005-04-26 FR FR05C0021C patent/FR05C0021I2/fr active Active
- 2005-10-07 CY CY20051101221T patent/CY1110359T1/el unknown
-
2007
- 2007-01-31 HK HK07101074.0A patent/HK1095161A1/xx not_active IP Right Cessation
- 2007-09-28 JP JP2007254101A patent/JP4680245B2/ja not_active Expired - Lifetime
- 2007-12-18 NL NL300326C patent/NL300326I2/nl unknown
-
2008
- 2008-06-03 CY CY20081100583T patent/CY1108113T1/el unknown
-
2011
- 2011-01-13 JP JP2011004965A patent/JP5362750B2/ja not_active Expired - Lifetime
-
2012
- 2012-03-16 JP JP2012060619A patent/JP2012193179A/ja not_active Ceased
-
2014
- 2014-11-13 CY CY20141100947T patent/CY1115749T1/el unknown
- 2014-12-18 JP JP2014255849A patent/JP5869658B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1110359T1 (el) | Εμβολια με βαση σιρκοϊους χοιρων | |
CN111088283B (zh) | mVSV病毒载体及其病毒载体疫苗、一种基于mVSV介导的新冠肺炎疫苗 | |
RU2565537C2 (ru) | Конструкция | |
RU2008102654A (ru) | Инактивированные химерные вакцины и связанные с ними способы применения | |
Wang et al. | Efficacy of DNA vaccines against infectious bursal disease virus in chickens enhanced by coadministration with CpG oligodeoxynucleotide | |
EA200100425A1 (ru) | Новые способы терапевтической вакцинации | |
EA200801756A1 (ru) | Противогриппозные вакцины, содержащие гемагглютинин и белки матрикса | |
Maity et al. | Protective efficacy of a DNA vaccine construct encoding the VP2 gene of infectious bursal disease and a truncated HSP70 of Mycobacterium tuberculosis in chickens | |
ES2640961T3 (es) | Virus de la estomatitis vesicular para vacunas de sensibilización y refuerzo | |
BR9814204A (pt) | "obtenção de vacinas destinadas a prevenir os efeitos patogênicos associados a uma infecção retroviral" | |
Diaz-San Segundo et al. | Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine | |
BR0312474A (pt) | Partìcula viral adjuvante | |
RU2015113826A (ru) | Выделение вируса, родственного парвовирусу-2 собак, от енота | |
Kong et al. | Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization | |
Jia et al. | Oral immunization of recombinant Lactococcus lactis and Enterococcus faecalis expressing dendritic cell targeting peptide and hexon protein of Fowl adenovirus 4 induces protective immunity against homologous infection | |
WO2023023940A1 (zh) | 一种诱导广谱抗冠状病毒的t细胞疫苗免疫原及其应用 | |
Kim et al. | BacMam expressing highly glycosylated porcine interferon alpha induces robust antiviral and adjuvant effects against foot-and-mouth disease virus in pigs | |
Cedillo-Barron et al. | Immunogenicity of plasmids encoding T and B cell epitopes of foot-and-mouth disease virus (FMDV) in swine | |
DE50010240D1 (de) | Impfstoff gegen infektionen mit lentiviren, wie dem felinen immunschwäche-virus der katze | |
RU2660566C2 (ru) | Иммунизация вектором на основе вируса бешенства, экспрессирующим чужеродный белковый антиген | |
Hsieh et al. | The effect of co-administration of DNA carrying chicken interferon-γ gene on protection of chickens against infectious bursal disease by DNA-mediated vaccination | |
EP3347044A1 (en) | Bird flu vaccine combination comprising virus-like particles and novel adjuvants | |
Borhani et al. | A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies | |
DE69633919D1 (de) | Mehrzweckvakzine gegen umhüllte viren | |
FR2829498B1 (fr) | Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins |